PureHealth’s Ardent Health expands US footprint with strategic acquisition

UAE-based PureHealth has continued to strengthen its international presence through its associate, Ardent Health, which has recently acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care.

This marks a significant expansion in Ardent’s US network.

The newly added clinics, six in New Mexico under Lovelace Health System and 12 in Oklahoma under Hillcrest HealthCare System, represent a crucial step in Ardent’s growth strategy.

The acquisition aligns with PureHealth’s ongoing focus on driving global expansion through a targeted bolt-on approach.

This strategy aims to enhance healthcare accessibility across the globe while bolstering its presence in high-potential markets.

This transaction builds upon Ardent’s recent acquisition of nine urgent care centers in East Texas and Topeka, Kansas, in 2024.

The additional locations increase Ardent’s reach in mid-sized urban communities across the United States, advancing its goal of creating a consumer-centric healthcare ecosystem.

PureHealth marks a key milestone in its international operations

The transaction also reflects the growing value of PureHealth’s investment in Ardent Health, which saw a successful initial public offering (IPO) in July 2024, just over a year after PureHealth’s investment in the company in May 2023.

Marty Bonick, CEO of Ardent Health, expressed enthusiasm about the expansion, stating, “Expanding our urgent care footprint represents significant progress in our mission to create a consumer-focused ecosystem of care in each of the communities we serve.”

He emphasised that the move would improve patient access to convenient, high-quality services, adding, “These additional access points also bring new patients into our network while creating enhanced capacity to serve patients within our clinics and emergency departments.”

Ardent Health’s strong performance underscores the effectiveness of its strategy.

In its third-quarter 2024 results, the company reported $1.45bn in revenue, a 5.2 per cent increase compared to the same period in 2023. Admissions also grew by 6.4 per cent year-over-year, further signalling the health system’s continued momentum.